Literature DB >> 16960143

BCL-xL regulates synaptic plasticity.

Elizabeth Jonas1.   

Abstract

Mitochondria are the predominant organelle within many presynaptic terminals. During times of high synaptic activity, they affect intracellular calcium homeostasis and provide the energy needed for synaptic vesicle recycling and for the continued operation of membrane ion pumps. Recent discoveries have altered our ideas about the role of mitochondria in the synapse. Mitochondrial localization, morphology, and docking at synaptic sites may indeed alter the kinetics of transmitter release and calcium homeostasis in the presynaptic terminal. In addition, the mitochondrial ion channel BCL-xL, known as a protector against programmed cell death, regulates mitochondrial membrane conductance and bioenergetics in the synapse and can thereby alter synaptic transmitter release and the recycling of pools of synaptic vesicles. BCL-xL, therefore, not only affects the life and death of the cell soma, but its actions in the synapse may underlie the regulation of basic synaptic processes that subtend learning, memory and synaptic development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960143     DOI: 10.1124/mi.6.4.7

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  35 in total

1.  Effect of Bcl-2 rs956572 SNP on regional gray matter volumes and cognitive function in elderly males without dementia.

Authors:  Mu-En Liu; Chu-Chung Huang; Jen-Ping Hwang; Albert C Yang; Pei-Chi Tu; Heng-Liang Yeh; Chen-Jee Hong; Ying-Jay Liou; Jin-Fan Chen; Ching-Po Lin; Shih-Jen Tsai
Journal:  Age (Dordr)       Date:  2011-12-25

Review 2.  Increased expression of the anti-apoptotic protein Bcl-xL in the brain is associated with resilience to stress-induced depression-like behavior.

Authors:  Nikolay N Dygalo; Tatyana S Kalinina; Veta V Bulygina; Galina T Shishkina
Journal:  Cell Mol Neurobiol       Date:  2012-01-26       Impact factor: 5.046

3.  Postnatal developmental regulation of Bcl-2 family proteins in brain mitochondria.

Authors:  Lucian Soane; Zachary T Siegel; Rosemary A Schuh; Gary Fiskum
Journal:  J Neurosci Res       Date:  2008-05-01       Impact factor: 4.164

4.  Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.

Authors:  Erick T Tatro; Ian P Everall; Marcus Kaul; Cristian L Achim
Journal:  Brain Res       Date:  2009-06-21       Impact factor: 3.252

5.  Paeoniflorin, a natural neuroprotective agent, modulates multiple anti-apoptotic and pro-apoptotic pathways in differentiated PC12 cells.

Authors:  Di Wang; Hei Kiu Wong; Yi-Bin Feng; Zhang-Jin Zhang
Journal:  Cell Mol Neurobiol       Date:  2013-02-24       Impact factor: 5.046

6.  Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants.

Authors:  O Malkesman; D R Austin; T Tragon; I D Henter; J C Reed; M Pellecchia; G Chen; H K Manji
Journal:  Mol Psychiatry       Date:  2011-07-05       Impact factor: 15.992

7.  BDNF signaling: Harnessing stress to battle mood disorder.

Authors:  Pawel Licznerski; Elizabeth A Jonas
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-28       Impact factor: 11.205

Review 8.  Mitochondrial fragmentation in neurodegeneration.

Authors:  Andrew B Knott; Guy Perkins; Robert Schwarzenbacher; Ella Bossy-Wetzel
Journal:  Nat Rev Neurosci       Date:  2008-07       Impact factor: 34.870

9.  Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons.

Authors:  Takahiro Miyawaki; Toshihiro Mashiko; Dimitry Ofengeim; Richard J Flannery; Kyung-Min Noh; Sho Fujisawa; Laura Bonanni; Michael V L Bennett; R Suzanne Zukin; Elizabeth A Jonas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

10.  Bcl-xL inhibitor ABT-737 reveals a dual role for Bcl-xL in synaptic transmission.

Authors:  John A Hickman; J Marie Hardwick; Leonard K Kaczmarek; Elizabeth A Jonas
Journal:  J Neurophysiol       Date:  2007-12-26       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.